Waters Cheryl H
Department of Neurology, Division of Movement Disorders, Columbia University, 710 W 168th Street, New York, NY 10032, USA.
Parkinsonism Relat Disord. 2002 Oct;9(1):15-21. doi: 10.1016/s1353-8020(02)00040-8.
Most patients with Parkinson's disease (PD) receiving chronic levodopa therapy eventually manifest one or more motor response complications, including 'wearing-off' phenomena and on-off phenomena. Additionally, as the disease progresses, motor, neurologic, and neuropsychiatric complications increase and may include freezing spells, falls, dementia, depression and psychosis. The management of patients with advanced PD presents a special clinical challenge because patients may experience an enhanced sensitivity to small changes in plasma levodopa levels and because they may suffer adverse reactions to antiparkinsonian drugs. Management of advanced PD is directed toward decreasing the dose of the offending drug while raising the dose of alternative drug with the goal of maintaining symptom control. In this article, the spectrum of late complications experienced by patients with advanced PD and their management are discussed.
大多数接受慢性左旋多巴治疗的帕金森病(PD)患者最终会出现一种或多种运动反应并发症,包括“剂末”现象和“开-关”现象。此外,随着疾病进展,运动、神经和神经精神并发症会增加,可能包括冻结步态、跌倒、痴呆、抑郁和精神病。晚期PD患者的管理面临特殊的临床挑战,因为患者可能对血浆左旋多巴水平的微小变化更为敏感,并且可能对抗帕金森病药物产生不良反应。晚期PD的管理旨在减少致病药物的剂量,同时增加替代药物的剂量,以维持症状控制。本文讨论了晚期PD患者所经历的一系列晚期并发症及其管理。